February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

Posted on 16 Febbraio 2020, English, Company, Italiano, Deutsch, French

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

Posted on 14 Febbraio 2020, English, Company, Italiano, Deutsch, French

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

Posted on 10 Febbraio 2020, English, Company, Italiano, Deutsch, French

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination.

We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation.

COSMED introduces Q-NRG, the new metabolic monitor for energy expenditure measurements in mechanically ventilated and spontaneous breathing patients in ICU

Posted on 08 Marzo 2018, English, Company, Italiano, Deutsch, French

indirect calorimetry

Rome (Italy) - March 2018 - COSMED, world-wide leader in the design of metabolic systems for clinical and human performance applications, announced today the release of a new product line of metabolic monitors for quick, accurate, intuitive and affordable indirect calorimetry.

COSMED receives Innovative Technology Designation from Vizient for K5 Wearable Metabolic System

Posted on 17 Novembre 2017, English, Company, Italiano, Deutsch, French

indirect calorimetry

Concord (California, USA) - November 2017 - COSMED announced its K5 Wearable Metabolic System has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country.

[12 3 4  >>